CF
WST icon

Corebridge Financial’s West Pharmaceutical WST Stock Holding History

Corebridge Financial’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,128
Closed -$3.83M – 2820
2025
Q1 		$3.83M Sell
17,128
-529
-3% -$146K 0.02% 769
2024
Q4 		$5.78M Sell
17,657
-1,344
-7% -$423K 0.03% 656
2024
Q3 		$5.7M Sell
19,001
-756
-4% -$232K 0.03% 683
2024
Q2 		$6.51M Buy
+19,757
New +$6.98M 0.04% 603

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Corebridge Financial's WST Position: Q2 2025 in Review

Corebridge Financial sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 17,128 shares — an estimated $3.83M sold.

Corebridge Financial first reported a position in WST in Q2 2024 and held it in 4 quarters. The position peaked at $6.51M in Q2 2024. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Corebridge Financial reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 17,128 West Pharmaceutical shares in Q2 2025, an estimated $3.83M.
  • Corebridge Financial first reported a position in West Pharmaceutical in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's West Pharmaceutical position peaked at $6.51M in Q2 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.